ASTH Astrana Health, Inc.

Did the company actually spend money buying back stock in 3+ of the last 4 quarters?

Bought back stock in 2/4 quarters. Q1 2025: $11M, Q3 2025: $0M, Q2 2025: $-11M, Q3 2023: $0M

Is the most recent quarter's buyback spend more than 15% above the trailing average?

Latest quarter $11M vs trailing avg $-3M (-405%)

What percentage of free cash flow is going to buybacks? Bull: 30-80%. Bear: <10% or >80%.

Buyback $0M / FCF $25M = 1% of FCF

How fast are they shrinking the float? Bull: 2%+ annually. Bear: under 0.5%.

Repurchased 900,000 shares = 2.6% of 46,575,699 outstanding (annualized)

Are officers and directors buying stock with their own money on the open market?

29 open-market purchases by 6 insiders

• ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp () bought 250,000 shares at $37.00 on 2022-06-17
• ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp () bought 40,000 shares at $73.67 on 2021-08-17
• Sim Brandon (See Remarks) bought 1,000 shares at $31.40 on 2021-05-13
• ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp () bought 100,000 shares at $24.50 on 2021-04-28
• Lam Thomas S. (President and Co-CEO) bought 5,000 shares at $17.28 on 2020-09-14
• Sim Kenneth T. (Executive Chairman and Co-CEO) bought 5,000 shares at $17.23 on 2020-09-14
• Sim Kenneth T. (Executive Chairman and Co-CEO) bought 1,000 shares at $17.20 on 2020-09-14
• Sim Brandon (See Remarks) bought 1,000 shares at $17.20 on 2020-09-14
• Sim Brandon (See Remarks) bought 5,000 shares at $17.23 on 2020-09-14
• Sim Brandon (See Remarks) bought 5,000 shares at $17.60 on 2020-09-10

Are insider purchases happening during the same quarters the company is actively buying back stock?

Insider buying coincided with company buybacks in 1 of 4 quarters

• Q3 2023: ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp bought while company spent $0M

Looking at all open-market transactions, are insiders net buyers or net sellers?

Insiders bought $20M, sold $56M (net selling)

Active buyback + insiders net selling 3x+ more than buying. Company cash may be supporting price while insiders exit.

No buyback-insider divergence detected